Chromosome 22Q (DiGeorge Syndrome)
The Chromosome 22q11.2 Deletion Syndrome Specialty Clinic at Children's Hospital Colorado evaluates children with 22q11.2 Deletion Syndrome and provides comprehensive management and ongoing multi-disciplinary care for children and families affected by the syndrome. Our specially trained clinicians provide patients and families with the resources necessary to understand the diagnosis, determine the appropriate treatments and therapies and cope with the challenges involved with the syndrome.
What is 22q11.2 Deletion Syndrome?
22q11.2 Deletion Syndrome (22q), also known as DiGeorge Syndrome and Velo Cardio Facial Syndrome (VCFS), is a relatively common genetic occurrence that appears equally among males and females and across all racial backgrounds. In most cases 22q appears sporadically and babies born with it have no family history of this syndrome. There is nothing a parent did or didn't do to cause the syndrome. However, people with 22 have a 50% chance of passing it on to their children.
Characteristics of 22q11.2 Deletion Syndrome
This syndrome is caused by a very small piece of genetic material, or genes, missing from the long arm (known as the "q" arm) of the 22nd chromosome. The name 22q11.2 actually describes the location of the missing genes. This micro deletion is associated with 185 conditions that can affect nearly every system in the body. While conditions associated with the syndrome vary widely from person to person, some of the more common findings include:
- Congenital heart defects
- Palate abnormalities
- Skeletal abnormalities
- Immune system problems
- Learning disabilities
- Feeding problems
- Chronic constipation
- Kidney abnormalities
- Psychosocial concerns
- Hypernasal speech
- Developmental milestone delays
Diagnosis and treatment
Because 22q11.2 Deletion Syndrome has such wide ranging and variable characteristics it can often go unrecognized and undiagnosed for years. However, it can be detected by a simple blood test called array comparative genomic hybridization. A FISH (fluorescence in situ hybridization) test may also be used to detect the condition.
Once diagnosed, there is no one plan of treatment for 22q since it affects everyone differently. The treatment and management of a child with 22q must be tailored to the individual based on age and symptoms. Because it is a multisystem disorder, it may be necessary to have multiple, ongoing evaluations, treatments and interventions. However, it is important to note that some children with 22q have few signs or symptoms and require minimal assistance; most others respond well to tailored treatment programs.
Resources available for 22q11.2 Deletion Syndrome care
Following diagnosis, the Chromosome 22q11.2 Specialty Clinic works with families to coordinate a prescribed care program, directing families to the appropriate resources to address specific symptoms. This can include the services of:
Why choose Children's Hospital Colorado for 22q11.2 Deletion Syndrome care?
The Chromosome 22q11.2 Deletion Syndrome Specialty Clinic is the first medical center in the Rocky Mountain region to take a comprehensive and integrated approach to managing the syndrome, drawing on an extensive range of pediatric services and specialists at Children's Colorado to provide the highest level of expertise to our patients. As experts in the problems and challenges of 22q, we bring together recognized pediatric experts in areas such as genetics, cardiology, immunology, craniofacial, otolaryngology, psychiatry, child development and endocrinology as needed to work with each family to meet their child's specific needs.
In addition, the clinic uniquely provides families with educational resources and the opportunity to connect with other families through a parent-directed network and support group specifically for those affected by 22q.
We're here to provide answers and solutions for families affected by 22q11.2 Deletion Syndrome. For more information or to set up an appointment, please contact us:
Get to know our pediatric experts.